All lobbying filings

DESIMONE CONSULTING, LLC

DESIMONE CONSULTING, LLC filed a Q3 report for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) on October 13, 2026, reporting $30,000 in lobbying income.

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) · trade group representing U.S. pharmaceutical research and biotechnology companies

All filings by DESIMONE CONSULTING, LLC · Everything PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 13, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues related to patient access and pricing. Issues related to policy changes to Medicare Part D. Issues related to 340B reform. Issues related to Most Favored Nation (MFN) policy. Issues related to insurance policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.